Momenta Pharmaceuticals Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Momenta Phama's (MNTA) Q2 Loss Narrower than Expected
August 4, 2016 8:41 AM EDTMomenta Phama (NASDAQ: MNTA) reported Q2 EPS of ($0.31), $0.01 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $26.4 million versus the consensus estimate of $23.55 million.
For earnings history and earnings-related data on Momenta Phama (MNTA) click here.
... More